BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Events

  The Value of Automating Pipette Calibration Management

  See how the integration of Blue Mountain Regulatory Asset Manager (BMRAM), Rainin PipetteX, and Rainin Service can dramatically reduce the administrative burden and cost of pipette calibration programs while ensuring regulatory readiness.

  August 7, 2025
• 

  Events

  Antibody Therapeutics Roundtables - San Francisco

  an exclusive, highly interactive event that unites senior-level scientists and executives from leading pharmaceutical and biotech organizations. This one-day forum will address cutting-edge innovations and real-world challenges across the full spectrum of antibody drug development.

  August 7, 2025
• 

  IN PARTNERSHIP WITH CRESSET

  From Chat Bots to World Order: The Race for the 21st Century’s Operating System

  In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses the emerging geopolitical battle for AI supremacy and global AI governance with Mutlu Dogruel, VP of AI and Mark Mackey, CSO of Cresset.

  August 7, 2025

   · 

  1 min read

   · 

  Lori Ellis
• 

  Earnings

  Despite Safety Drama, Sarepta Beats Q2 Estimates—But No Thanks to Elevidys Sales

  Sarepta did not hold an investor call for its second-quarter earnings report or provide an updated full-year revenue outlook.

  August 7, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Cancer

  Big Pharma-Backed mRNA Startup Bags $153M Series B Amid Policy Headwinds

  Strand Therapeutics’ lead asset is STX-001, an intra-tumor self-replicating mRNA therapy that carries a payload expressing the immunomodulatory protein IL-12.

  August 7, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Job Trends

  Hiring Outlook: Latest Job, Application Numbers Highlight Tough Job Market

  Higher competition for fewer roles remains the status quo for biopharma professionals, based on BioSpace data. Additionally, the U.S. Bureau of Labor Statistics has reported that recent job growth is lower than previously believed.

  August 7, 2025

   · 

  4 min read

   · 

  Angela Gabriel
• 

  Earnings

  Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value

  From the price of forthcoming weight loss pill orforglipron, to Most Favored Nation drug pricing and the market battle with Novo Nordisk, pricing was the number one issue for Eli Lilly on its second quarter earnings call.

  August 7, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Mergers & acquisitions

  Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity

  There is no certainty that the buyout will come to pass, according to The Financial Times, which first reported the rumors.

  August 7, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Obesity

  UPDATE: Lilly’s Oral Weight Loss Drug Underdelivers, But Executives See Real World Opportunity

  Eli Lilly’s orforglipron cut body weight to a lesser extent than rival Novo Nordisk’s semaglutide, falling into analysts’ bear scenario for the oral med. Executives brushed off the concerns and said the drug will still have a wide advantage on the market.

  August 7, 2025

   · 

  4 min read

   · 

  Annalee Armstrong
• Press Releases

  Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter

  August 7, 2025

   · 

  19 min read